Acta Biomater 127:276286 Huang A et al (2022) Sorafenib-loaded Cu(2x)Se Nanoparticles boost photothermal-synergistic targeted therapy against hepatocellular carcinoma
Hair loss sometimes occurs 3-6 months into therapy
This delayed gastric emptying is one reason these medications reduce appetite and help with weight managementyou feel full longer after eating
BPC-157 Synonyms / Designations: BPC-157, Body Protection Compound-157, PL-14736 (research designation) CAS Number: 1628202-19-6 Molecular Formula: C64H102N16O24 Molecular Weight: 1479.6 g/mol Purity: 99 % (HPLC) Appearance: White to off-white lyophilised powder Pack Size: 5 mg (total) Storage: Desiccated, protected from light, stored at 20 C or below Solubility: Soluble in water and buffered aqueous solutions Description & Mechanism BPC-157 is a synthetic oligopeptide consisting of fifteen amino acids, corresponding to a defined sequence originally identified within a larger gastric-derived protein
We would always recommend tapering the medication really gradually in order to avoid rebound effects
Photographs of the vial, label, batch details and the sellers listing are useful clinical and regulatory information
